Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Kuter

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
British Journal of Haematology|October 6, 2021
Novel therapies for immune thrombocytopeniaDavid J Kuter
The Oncologist|March 30, 2004
Thrombotic complications of central venous catheters in cancer patientsDavid J Kuter
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
The promise of thrombopoietins in the treatment of ITPDavid J Kuter
British Journal of Haematology|June 2, 2021
Exacerbation of immune thrombocytopenia following COVID-19 vaccinationDavid J Kuter
Blood Reviews|November 24, 2021
The structure, function, and clinical use of the thrombopoietin receptor agonist avatrombopagDavid J Kuter
Cancer Treatment and Research|November 6, 2010
RomiplostimDavid J Kuter
Seminars in Hematology|July 13, 2010
Biology and chemistry of thrombopoietic agentsDavid J Kuter
Vox Sanguinis|March 6, 2003
Apoptosis in platelets during ex vivo storageDavid J Kuter
Hematology. American Society of Hematology. Education Program|December 9, 2022
Warm autoimmune hemolytic anemia and the best treatment strategiesDavid J Kuter
International Journal of Hematology|July 4, 2013
The biology of thrombopoietin and thrombopoietin receptor agonistsDavid J Kuter
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|October 6, 2021
Novel therapies for immune thrombocytopeniaDavid J Kuter
The Oncologist|March 30, 2004
Thrombotic complications of central venous catheters in cancer patientsDavid J Kuter
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
The promise of thrombopoietins in the treatment of ITPDavid J Kuter
British Journal of Haematology|June 2, 2021
Exacerbation of immune thrombocytopenia following COVID-19 vaccinationDavid J Kuter
Blood Reviews|November 24, 2021
The structure, function, and clinical use of the thrombopoietin receptor agonist avatrombopagDavid J Kuter
Cancer Treatment and Research|November 6, 2010
RomiplostimDavid J Kuter
Seminars in Hematology|July 13, 2010
Biology and chemistry of thrombopoietic agentsDavid J Kuter
Vox Sanguinis|March 6, 2003
Apoptosis in platelets during ex vivo storageDavid J Kuter
Hematology. American Society of Hematology. Education Program|December 9, 2022
Warm autoimmune hemolytic anemia and the best treatment strategiesDavid J Kuter
International Journal of Hematology|July 4, 2013
The biology of thrombopoietin and thrombopoietin receptor agonistsDavid J Kuter
Pageof 16